Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in T. Rowe Price Health Sciences Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
T. Rowe Price Health Sciences Fund (PRHSX) has returned -9.65% so far this year and 20.86% over the past 12 months. Over the last ten years, PRHSX has returned 11.42% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
T. Rowe Price Health Sciences Fund
- 1D
- 0.37%
- 1M
- -9.33%
- YTD
- -9.65%
- 6M
- 18.49%
- 1Y
- 20.86%
- 3Y*
- 9.06%
- 5Y*
- 4.83%
- 10Y*
- 11.42%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jan 2, 1996, PRHSX's average daily return is +0.06%, while the average monthly return is +1.18%. At this rate, your investment would double in approximately 4.9 years.
Historically, 63% of months were positive and 37% were negative. The best month was Jun 2000 with a return of +27.0%, while the worst month was Mar 2000 at -17.8%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, PRHSX closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +13.6%, while the worst single day was Mar 16, 2020 at -11.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.98% | 0.64% | -9.33% | -9.65% | |||||||||
| 2025 | 6.20% | -1.84% | -4.11% | -0.09% | -6.50% | 3.99% | -1.31% | 4.15% | 2.15% | 7.83% | 9.09% | 11.48% | 33.71% |
| 2024 | 2.05% | 4.06% | 1.66% | -4.97% | 2.31% | 2.85% | 2.68% | 5.19% | -1.95% | -5.00% | 1.49% | -7.62% | 1.82% |
| 2023 | 0.58% | -4.69% | 1.92% | 3.57% | -2.94% | 2.90% | -0.14% | -1.51% | -3.85% | -3.89% | 5.56% | 6.27% | 3.03% |
| 2022 | -12.38% | -0.39% | 4.75% | -8.57% | -0.90% | -0.56% | 5.58% | -3.09% | -4.25% | 7.68% | 4.16% | -3.01% | -12.22% |
| 2021 | 2.35% | -1.82% | -0.77% | 4.95% | -0.92% | 5.61% | 2.02% | 4.16% | -4.66% | 4.21% | -4.90% | 3.22% | 13.50% |
Benchmark Metrics
T. Rowe Price Health Sciences Fund has an annualized alpha of 6.64%, beta of 0.85, and R² of 0.60 versus S&P 500 Index. Calculated based on daily prices since January 03, 1996.
- This fund participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (99.82%) than losses (77.14%) — typical of diversified or defensive assets.
- This fund generated an annualized alpha of 6.64% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
- With beta of 0.85 and R² of 0.60, this fund moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.
- Alpha
- 6.64%
- Beta
- 0.85
- R²
- 0.60
- Upside Capture
- 99.82%
- Downside Capture
- 77.14%
Expense Ratio
PRHSX has an expense ratio of 0.80%, placing it in the medium range.
Return for Risk
Risk / Return Rank
PRHSX ranks 52 for risk / return — on par with similar mutual funds. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and compare them to a chosen benchmark (S&P 500 Index).
| PRHSX | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | 0.90 | +0.02 |
Sortino ratioReturn per unit of downside risk | 1.60 | 1.39 | +0.22 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.21 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | 1.40 | +0.12 |
Martin ratioReturn relative to average drawdown | 4.47 | 6.61 | -2.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore PRHSX risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
T. Rowe Price Health Sciences Fund provided a 26.63% dividend yield over the last twelve months, with an annual payout of $20.10 per share. The fund has been increasing its distributions for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $20.10 | $20.10 | $10.25 | $4.58 | $1.59 | $7.76 | $7.08 | $10.01 | $4.40 | $5.23 | $2.69 | $7.81 |
Dividend yield | 26.63% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
Monthly Dividends
The table displays the monthly dividend distributions for T. Rowe Price Health Sciences Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.10 | $20.10 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.25 | $10.25 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.58 | $4.58 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.59 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.76 | $7.76 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the T. Rowe Price Health Sciences Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the T. Rowe Price Health Sciences Fund was 42.96%, occurring on Nov 20, 2008. Recovery took 330 trading sessions.
The current T. Rowe Price Health Sciences Fund drawdown is 12.49%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -42.96% | Jan 11, 2008 | 219 | Nov 20, 2008 | 330 | Mar 17, 2010 | 549 |
| -41.17% | Nov 3, 2000 | 427 | Jul 23, 2002 | 408 | Mar 5, 2004 | 835 |
| -29.72% | Mar 6, 2000 | 30 | Apr 14, 2000 | 59 | Jul 11, 2000 | 89 |
| -28.97% | Feb 20, 2020 | 23 | Mar 23, 2020 | 39 | May 18, 2020 | 62 |
| -27.61% | Sep 3, 2021 | 198 | Jun 16, 2022 | 547 | Aug 21, 2024 | 745 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...